Servier
Clinical trials sponsored by Servier, explained in plain language.
-
New hope for asian brain tumor patients: targeted pill slows cancer growth
Disease control OngoingThis study tests an experimental pill, vorasidenib, in Asian patients with a slow-growing but serious brain tumor (grade 2 glioma) that has a specific genetic mutation (IDH1 or IDH2). About 57 participants will receive either the drug or a placebo to see if it delays tumor progre…
Phase: PHASE3 • Sponsor: Servier • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New targeted pill shows promise for rare bile duct cancer in small trial
Disease control OngoingThis study tests a daily pill called ivosidenib in 12 Japanese patients with advanced bile duct cancer that has an IDH1 mutation and has already been treated with other therapies. The goal is to see if the drug can stop the cancer from growing for at least 6 months. Participants …
Phase: PHASE2 • Sponsor: Servier • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC